Roles > Brassica napus metabolite
Page last updated: 2024-08-05 15:04:52
Brassica napus metabolite
Any plant metabolite that is produced by rapeseed (Brassica napus).
ChEBI ID: 140165
Members (10)
Member | Definition | Class |
(E)-2-methoxycinnamic acid | A member of the class of cinnamic acids that is trans-cinnamic acid carrying a methoxy substituent at position 2 on the benzene ring. | (E)-2-methoxycinnamic acid |
1,3-dicapryloylglycerol | A 1,3-diglyceride in which both acyl groups are specified as octanoyl. | 1,3-dioctanoylglycerol |
3-methoxybenzaldehyde | A member of the class of benzaldehydes in which the hydrogen at position 3 of benzaldehyde has been replaced by a methoxy group. | 3-methoxybenzaldehyde |
4',7-dihydroxyflavanone | A dihydroxyflavanone in which the two hydroxy substituents are located at positions 4' and 7. | 4',7-dihydroxyflavanone |
5-methoxyindoleacetic acid | A member of the class of indole-3-acetic acids in which the hydrogen at position 5 of indole-3-acetic acid has been replaced by a methoxy group. | 5-methoxyindole-3-acetic acid |
5-methoxyresorcinol | A member of the class of resorcinols that is phloroglucinol in which one of the phenolic hydrogens has been replaced by a methyl group. | flamenol |
8-nitroguanosine 3',5'-cyclic monophosphate | A 3',5'-cyclic purine nucleotide that is guanosine 3',5'-cyclic monophosphate in which the hydrogen at position 8 on the purine fragment has been replaced by a nitro group. | 8-nitroguanosine 3',5'-cyclic monophosphate |
carboxymethyl-coenzyme a | An S-alkyl-CoA having carboxymethyl as the S-alkyl component. | carboxymethyl-CoA |
eupatorin | A trimethoxyflavone that is 6-hydroxyluteolin in which the phenolic hydogens at positions 4', 6 and 7 have been replaced by methyl groups. | eupatorin |
quercetin 3-o-gentiobioside | A quercetin O-glycoside in which the hydroxy hydrogen at position 3 of quercetin has been replaced by a gentiobiosyl group. | quercetin 3-beta-gentiobioside |
Research
Studies (197)
Timeframe | Studies, Drugs with This Role(%) | All Drugs % |
pre-1990 | 35 (17.77) | 18.7374 |
1990's | 23 (11.68) | 18.2507 |
2000's | 27 (13.71) | 29.6817 |
2010's | 91 (46.19) | 24.3611 |
2020's | 21 (10.66) | 2.80 |
Study Types
Publication Type | Studies, Drugs with this Role (%) | All Drugs (%) |
Trials | 2 (0.93%) | 5.53% |
Reviews | 20 (9.30%) | 6.00% |
Case Studies | 2 (0.93%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 191 (88.84%) | 84.16% |
Protein Targets (20)
Potency Measurements
Inhibition Measurements
Activation Measurements